it simply requires the right approach
The company operates across three verticals (Pharma CDMO, API+, Specialty Chemicals), with cutting-edge capabilities in ADCs (antibody-drug conjugates) and oligonucleotides that very few Indian companies possess New Executive Chairman Umang Vohra (formerly CEO of Cipla a heavyweight appointment) signaled ambitious intent: Having spent over three decades in this industry, I am excited to be part of a platform that is anchored in science with capabilities such as ADCs and oligonucleotides, which are well-differentiated and hard to replicate.
Importantly, these medications already offer significant cardiometabolic advantages for many patients
Semax provides BDNF support for neuron survival and maintenance
Semaglutide is a glucagon-like peptide-1 (GLP-1) analog that was FDA-approved in 2017 for treatment of type II diabetes and in 2021 for treatment for chronic weight management in adults with obesity or overweight with at least one weight-related condition
The improved physical activity as an additional advantage, as it has been observed that individuals using these medications may experience increased motivation to engage in exercise and physical activity